EVGN:NASDAQ
エボジェン
$0.75
arrow_downward
-1.83%(-0.014) 1 日
5月4日, 16:00:01 GMT-4 · USD
search
すべての記号
1 日
5 日
1 か月
6 か月
年初来
1 年
5 年
最大
| 記号 | 価格 | 変化 | 変化率 |
|---|
insights_autoEVGN の上位の分析情報を生成しています...
始値
$0.76
高値
$0.80
安値
$0.74
時価総額
655.47万
平均出来高
8.83万
取引量
4.31万
52 週高値
$2.42
52 週安値
$0.72
EPS
-$1.80
ベータ版
1.39
発行済株式数
989.40万
従業員数
52
ニュース記事
ウェブの情報から
プロフィール
Evogene is a computational chemistry company based in Israel, specializing in the generative design of small molecules for the pharmaceutical and agricultural industries. At the core of its technology is ChemPass AI, a proprietary generative AI engine that enables the design of novel, highly potent small molecules optimized across multiple critical parameters. This powerful platform significantly improves success rates while reducing development time and costs. Built on this powerful technological foundation, and through strategic partnerships alongside internal product development, Evogene is focused on creating breakthrough products driven by the integration of scientific innovation with real-world industry needs.
In 2024, the company began collaborating with Google Cloud to develop an AI-powered generative model aimed at discovering small molecules for drug development and sustainable agriculture. Wikipedia
エボジェン について